ChartMill assigns a Buy % Consensus number of 83% to PRAX. The Buy consensus is the weighted average rating of the current analysts ratings.
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-12-29 | BTIG | Maintains | Buy -> Buy |
| 2025-12-15 | Oppenheimer | Maintains | Outperform -> Outperform |
| 2025-12-09 | Guggenheim | Maintains | Buy -> Buy |
| 2025-12-09 | Jefferies | Maintains | Buy -> Buy |
| 2025-12-08 | TD Cowen | Maintains | Buy -> Buy |
| 2025-12-08 | BTIG | Maintains | Buy -> Buy |
| 2025-12-08 | Needham | Maintains | Buy -> Buy |
| 2025-12-08 | Truist Securities | Maintains | Buy -> Buy |
| 2025-12-08 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-12-05 | Needham | Maintains | Buy -> Buy |
| 2025-12-05 | Wedbush | Maintains | Underperform -> Underperform |
| 2025-12-05 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2025-12-01 | Needham | Reiterate | Buy -> Buy |
| 2025-11-25 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-11-19 | BTIG | Initiate | Buy |
| 2025-11-13 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2025-11-06 | Wedbush | Maintains | Underperform -> Underperform |
| 2025-10-20 | Wedbush | Maintains | Underperform -> Underperform |
| 2025-10-17 | Chardan Capital | Maintains | Buy -> Buy |
| 2025-10-17 | Guggenheim | Maintains | Buy -> Buy |
| 2025-10-17 | Deutsche Bank | Maintains | Buy -> Buy |
| 2025-10-17 | Truist Securities | Reiterate | Buy -> Buy |
| 2025-10-16 | Needham | Maintains | Buy -> Buy |
| 2025-10-16 | Jefferies | Maintains | Buy -> Buy |
| 2025-10-16 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2025-09-18 | Jones Trading | Initiate | Buy |
| 2025-08-05 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2025-07-29 | Chardan Capital | Maintains | Buy -> Buy |
| 2025-07-18 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-07-08 | Oppenheimer | Maintains | Outperform -> Outperform |
21 analysts have analysed PRAX and the average price target is 410.52 USD. This implies a price increase of 38.21% is expected in the next year compared to the current price of 297.02.
The consensus rating for PRAXIS PRECISION MEDICINES I (PRAX) is 82.8571 / 100 . This indicates that analysts generally have a positive outlook on the stock.
The number of analysts covering PRAXIS PRECISION MEDICINES I (PRAX) is 21.